Protein & Cell >

2014 , Vol. 5 >Issue 3: 182 - 185

DOI: https://doi.org/10.1007/s13238-014-0024-5

LETTER

The gain of hydrogen peroxide resistance benefits growth fitness in mycobacteria under stress

  • Xiaojing Li 1,2 ,
  • Jun Tao 1 ,
  • Jiao Han 1 ,
  • Xinling Hu 1 ,
  • Yuling Chen 3 ,
  • Haiteng Deng 3 ,
  • Guangchun Zhang 4 ,
  • Xiaoxiang Hu 4 ,
  • Kaixia Mi , 1,5
Expand
  • 1. CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, CAS, Beijing 100101, China
  • 2. University of Chinese Academy of Sciences, Beijing 100082, China
  • 3. School of Life Sciences, Tsinghua University, Beijing 100084, China
  • 4. School of Life Sciences, China Agriculture University, Beijing 100094, China
  • 5. Beijing Key Laboratory of Drug Resistance and Resistome, Beijing 100101, China

Published date: 23 Jun 2014

Copyright

2014 This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Fold

Cite this article

Xiaojing Li , Jun Tao , Jiao Han , Xinling Hu , Yuling Chen , Haiteng Deng , Guangchun Zhang , Xiaoxiang Hu , Kaixia Mi . The gain of hydrogen peroxide resistance benefits growth fitness in mycobacteria under stress[J]. Protein & Cell, 2014 , 5(3) : 182 -185 . DOI: 10.1007/s13238-014-0024-5

References

Publishing order | Descend order by publishing year | Descend order by cited within
1
Armstrong JA, Hart PD (1971) Response of cultured macrophages to Mycobacterium tuberculosis, with observations on fusion of lysosomes with phagosomes. J Exp Med134: 713-740

DOI

2
Balbi KJ, Rocha EP, Feil EJ (2009) The temporal dynamics of slightly deleterious mutations in Escherichia coli and Shigella spp. Mol Biol Evol26: 345-355

DOI

3
Ford CB, Lin PL, Chase MR, Shah RR, Iartchouk O, Galagan J, Mohaideen N, Ioerger TR, Sacchettini JC, Lipsitch M (2011) Use of whole genome sequencing to estimate the mutation rate of Mycobacterium tuberculosis during latent infection. Nat Genet43: 482-486

DOI

4
Hershberg R, Lipatov M, Small PM, Sheffer H, Niemann S, Homolka S, Roach JC, Kremer K, Petrov DA, Feldman MW (2008) High functional diversity in Mycobacterium tuberculosis driven by genetic drift and human demography. PLoS Biol6: e311

DOI

5
Keren I, Wu Y, Inocencio J, Mulcahy LR, Lewis K (2013) Killing by bactericidal antibiotics does not depend on reactive oxygen species. Science339: 1213-1216

DOI

6
Kohanski MA, DePristo MA, Collins JJ (2010) Sublethal antibiotic treatment leads to multidrug resistance via radical-induced mutagenesis. Mol Cell37: 311-320

DOI

7
Kumar A, Farhana A, Guidry L, Saini V, Hondalus M, Steyn AJ (2011) Redox homeostasis in mycobacteria: the key to tuberculosis control? Expert Rev Mol Med13: e39

DOI

8
Little TJ, Allen JE, Babayan SA, Matthews KR, Colegrave N (2012) Harnessing evolutionary biology to combat infectious disease. Nat Med18: 217-220

DOI

9
Mestre O, Hurtado-Ortiz R, Dos Vultos T, Namouchi A, Cimino M, Pimentel M, Neyrolles O, Gicquel B (2013) High throughput phenotypic selection of Mycobacterium tuberculosis mutants with impaired resistance to reactive oxygen species identifies genes important for intracellular growth. PLoS One8: e53486

DOI

10
Podinovskaia M, Lee W, Caldwell S, Russell DG (2013) Infection of macrophages with Mycobacterium tuberculosis induces global modifications to phagosomal function. Cell Microbiol15: 843-859

DOI

11
Ramaswamy SV, Reich R, Dou S-J, Jasperse L, Pan X, Wanger A, Quitugua T, Graviss EA (2003) Single nucleotide polymorphisms in genes associated with isoniazid resistance in Mycobacterium tuberculosis. Antimicrob Agents Chemother47: 1241-1250

DOI

12
Timmins GS, Deretic V (2006) Mechanisms of action of isoniazid. Mol Microbiol62: 1220-1227

DOI

13
Wang ZY, Xiong M, Fu LY, Zhang HY (2013) Oxidative DNA damage is important to the evolution of antibiotic resistance: evidence of mutation bias and its medicinal implications. J Biomol Struct Dyn31: 729-733

DOI

14
WHO (2010). Multidrug and extensively drug-resistant TB (M/XDRTB): 2010 global report on surveillance and response. WHO/HTM/TB/20103

15
Wilson LG (2005) Commentary: medicine, population, and tuberculosis. Int J Epidemiol34: 521-524

DOI

Options
Outlines

/

〈 〉